These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 268398)

  • 41. [Myocardial lesions in several forms of progressive muscular atrophy].
    Popov'ian MD; Dubinskaia EE; Proshina OV; Tul'skaia MP; Loginova LA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1984; 84(3):330-5. PubMed ID: 6720172
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Fetal-blood creatine phosphokinase in the diagnosis of Duchenne's muscular dystrophy.
    N Engl J Med; 1978 Jun; 298(26):1479-80. PubMed ID: 652021
    [No Abstract]   [Full Text] [Related]  

  • 43. Metabolic effects of human growth hormone and of estrogens in boys with Duchenne muscular dystrophy.
    Rudman D; Chyatte SB; Patterson JH; Gerron GG; O'Beirne I; Barlow J; Jordan A; Shavin JS
    J Clin Invest; 1972 May; 51(5):1118-24. PubMed ID: 5057128
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Anaesthesia and serum creatine phosphokinase levels in patients with Duchenne's pseudohypertrophic muscular dystrophy.
    Richards WC
    Anaesth Intensive Care; 1972 Nov; 1(2):150-3. PubMed ID: 4668562
    [No Abstract]   [Full Text] [Related]  

  • 45. [Changes of serum creatine kinase levels in children with Duchenne muscular dystrophy].
    Sun SC; Peng YS; He JB
    Zhongguo Dang Dai Er Ke Za Zhi; 2008 Feb; 10(1):35-7. PubMed ID: 18289468
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prenatal diagnosis of Duchenne's muscular dystrophy.
    Mahoney MJ; Haseltine FP; Hobbins JC; Banker BQ; Caskey CT; Golbus MS
    N Engl J Med; 1977 Nov; 297(18):968-73. PubMed ID: 909543
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Effect of drug administration on the child with progressive muscular dystrophy].
    Nakahara T; Annaka S; Baba T; Kanno M
    Iryo; 1969 Oct; 23(10):1319-27. PubMed ID: 5364983
    [No Abstract]   [Full Text] [Related]  

  • 48. Duchenne's muscular dystrophy in six siblings. The case for early diagnosis and neonatal screening.
    Moosa A
    S Afr Med J; 1982 Nov; 62(21):765-7. PubMed ID: 7135141
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Serum CPK activities in long term follow up cases of progressive muscular dystrophy of Duchenne's type -with special reference to the course of disability and body weight (author's transl)].
    Konagaya M; Kohno K; Takayanagi T; Sobue I
    Rinsho Shinkeigaku; 1981 Feb; 21(2):150-7. PubMed ID: 7261497
    [No Abstract]   [Full Text] [Related]  

  • 50. Biochemical aspects of genetically determined progressive muscular dystrophies.
    Luca N; Haţegan D
    Rev Roum Neurol; 1973; 10(6):531-7. PubMed ID: 4771091
    [No Abstract]   [Full Text] [Related]  

  • 51. Verapamil and calcium-stimulated enzyme efflux from skeletal muscle.
    Anand R; Emery AE
    Clin Chem; 1982 Jul; 28(7):1482-4. PubMed ID: 7083559
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of chronic administration of verapamil in Duchenne muscular dystrophy.
    García AM; Goldemberg AL; Fernández H; Fortunato M; Ricci L; Trucco RE
    Gen Pharmacol; 1990; 21(6):939-42. PubMed ID: 2177715
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of coenzyme Q on serum levels of creatine phosphokinase in preclinical muscular dystrophy.
    Folkers K; Nakamura R; Littarru GP; Zellweger H; Brunkhorst JB; Williams CW; Langston JH
    Proc Natl Acad Sci U S A; 1974 May; 71(5):2098-102. PubMed ID: 4525474
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Steroid treatment of Duchenne's muscular dystrophy].
    Luz Aviles C; Gutiérrez C; Novoa F; Gil E; Stuardo A
    Rev Chil Pediatr; 1982; 53(3):187-91. PubMed ID: 6760264
    [No Abstract]   [Full Text] [Related]  

  • 55. [Serum creatine kinase and sulphydryl concentration after ischemic forearm work in patients and carriers of Duchenne's progressive muscular dystrophy].
    Moser H; Wiesmann U
    Klin Wochenschr; 1971 Apr; 49(8):488-94. PubMed ID: 5574169
    [No Abstract]   [Full Text] [Related]  

  • 56. Treatment of Duchenne's muscular dystrophy with penicillamine. Results of a double-blind trial.
    Roelofs RI; de Arango GS; Law PK; Kinsman D; Buchanan DC; Park JH
    Arch Neurol; 1979 May; 36(5):266-8. PubMed ID: 375881
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of allopurinol in Duchenne's muscular dystrophy.
    Hunter JR; Galloway JR; Brooke MM; Kutner MH; Rudman D; Vogel RL; Wardlaw CF; Gerron GG
    Arch Neurol; 1983 May; 40(5):294-9. PubMed ID: 6847424
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The use of concomitant serum pyruvate-kinase (PK) and creatine-phosphokinase (CPK) for carrier detection in Duchenne's muscular dystrophy through discriminant analysis.
    Zatz M; Otto PA
    J Neurol Sci; 1980 Sep; 47(3):411-7. PubMed ID: 7420115
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Progressive muscle disease in a young woman with family history of Duchenne's muscular dystrophy.
    Olson BJ; Fenichel GM
    Arch Neurol; 1982 Jun; 39(6):378-80. PubMed ID: 7092617
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Diagnostic value of determining lactate dehydrogenase in the blood in progressive muscular dystrophy of the Duchenne type and in detection of the carrier state of this disease].
    Niebrój-Dobosz I
    Neurol Neurochir Pol; 1985; 19(3):227-30. PubMed ID: 4047301
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.